Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
- PMID: 75545
- PMCID: PMC411230
- DOI: 10.1073/pnas.75.1.280
Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide
Abstract
The tridecamer d(A-A-T-G-G-T-A-A-A-A-T-G-G), which is complementary to 13 nucleotides of the 3'- and 5'-reiterated terminal sequences of Rous sarcoma virus 35S RNA, was added to chick embryo fibroblast tissue cultures infected with Rous sarcoma virus. Inhibition of virus production resulted. The inference emerges that the tridecamer and its counterpart with blocked 3'- and 5'-hydroxyl termini enter the chick fibroblast cells, hybridize with the terminal reiterated sequences at the 3' and 5' ends of the 35S RNA, and interfere with one or more steps involved in viral production and cell transformation. Likely sites of action are (i) the circularization step of the proviral DNA intermediate, and (ii) the initiation of translation, the latter being described in the following communication [Stephenson, M. L. & Zamecnik, P. C. (1978) Proc. Natl. Acad. Sci. USA 75, 285--288].
Similar articles
-
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.Proc Natl Acad Sci U S A. 1978 Jan;75(1):285-8. doi: 10.1073/pnas.75.1.285. Proc Natl Acad Sci U S A. 1978. PMID: 75546 Free PMC article.
-
Inhibition of Rous sarcoma virus assembly by treatment with 2',5' adenosine nucleotides.Virology. 1983 Jun;127(2):290-8. doi: 10.1016/0042-6822(83)90144-7. Virology. 1983. PMID: 6191438
-
In vitro synthesis of infectious transforming DNA by the avian sarcoma virus reverse transcriptase.J Virol. 1979 Jan;29(1):242-9. doi: 10.1128/JVI.29.1.242-249.1979. J Virol. 1979. PMID: 85719 Free PMC article.
-
3-Deazaadenosine, an inhibitor of adenosylhomocysteine hydrolase, inhibits reproduction of Rous sarcoma virus and transformation of chick embryo cells.Virology. 1978 Sep;89(2):494-505. doi: 10.1016/0042-6822(78)90191-5. Virology. 1978. PMID: 213879 No abstract available.
-
Rous sarcoma virus.Intervirology. 1986;26(1-2):1-60. doi: 10.1159/000149682. Intervirology. 1986. PMID: 2437068 Review. No abstract available.
Cited by
-
Specificity of oligonucleotide gene therapy (OGT) agents.Theranostics. 2022 Oct 9;12(16):7132-7157. doi: 10.7150/thno.77830. eCollection 2022. Theranostics. 2022. PMID: 36276652 Free PMC article. Review.
-
Broadening the Horizons of RNA Delivery Strategies in Cancer Therapy.Bioengineering (Basel). 2022 Oct 19;9(10):576. doi: 10.3390/bioengineering9100576. Bioengineering (Basel). 2022. PMID: 36290544 Free PMC article. Review.
-
RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment.Curr Pharm Biotechnol. 2024;25(16):2125-2137. doi: 10.2174/0113892010291042240130171709. Curr Pharm Biotechnol. 2024. PMID: 38347795 Review.
-
From Antisense RNA to RNA Modification: Therapeutic Potential of RNA-Based Technologies.Biomedicines. 2021 May 14;9(5):550. doi: 10.3390/biomedicines9050550. Biomedicines. 2021. PMID: 34068948 Free PMC article. Review.
-
The Non-Coding RNA Landscape in IgA Nephropathy-Where Are We in 2021?J Clin Med. 2021 May 28;10(11):2369. doi: 10.3390/jcm10112369. J Clin Med. 2021. PMID: 34071162 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources